Pharmaceutical Technology

NOVEMBER 25, 2022

The aim of the alliance is to bring to market precision therapy for patients globally. In September 2020, the company raised funds worth $318.8m Under the collaboration, the companies will utilise their capabilities to co-develop a new AI tumour vaccine R&D platform.

Pharmaceutical 98

Pharmaceutical Marketing Patients 98

Pharmaceutical Technology

DECEMBER 9, 2022

The alliance includes ENTR-701, a programme of Entrada for DM1. As per the deal, Vertex will make a $224m upfront payment to Entrada, in addition to an equity investment worth $26m. . Entrada is also entitled to get potential research, development, regulatory, and commercial milestone payments, worth up to $485m.

Food and Drug Administration 52

Food and Drug Administration Food Pharmaceutical Medicine 52

Pharmaceutical Technology

OCTOBER 28, 2022

PTC Therapeutics has signed a strategic financing partnership worth up to $1bn with funds managed by Blackstone to back the development of the former’s innovative product pipeline.

Networking 52

Networking Management Patients Pharmaceutical 52

pharmaphorum

AUGUST 3, 2022

The deal is the second for Roche in off-the-shelf or ‘allogeneic’ T cell therapies for cancer in less than a year, coming after it spent $150 million upfront on a five-year T cell receptor (TCR) alliance with Adaptimmune that could be worth up to $3 billion.

Pharmaceutical 92

Pharmaceutical 92

pharmaphorum

NOVEMBER 20, 2022

Immatics has become the latest partner for GSK in the area of cell therapy for cancer to see its alliance shelved, just two and a half years after being set up. All told, it could have been worth up to $1.15 The post GSK’s pullback from cell therapy continues as Immatics alliance ends appeared first on.

Leads 57

Leads 57

pharmaphorum

JANUARY 23, 2023

Morphic Therapeutic has lost Johnson & Johnson’s Janssen Pharma as a partner, following the termination of an alliance to develop drugs targeting integrins first agreed in 2019. The post Morphic loses second partner as J&J exits integrin alliance appeared first on. ” It was modified again in the middle of 2021.

Safety 52

Safety FDA Pharma 52

Pharmaceutical Technology

DECEMBER 23, 2022

This alliance is utilising the Axiomer ribonucleic acid (RNA) editing platform of ProQR to address ailments affecting the liver and nervous system. Additionally, Lilly holds the option to expand the collaboration for a fee worth $50m. The companies entered the initial agreement in September last year.

Medicine 131

Medicine Pharmaceutical Marketing Sales 131

Pharmaceutical Technology

SEPTEMBER 29, 2022

The alliance will leverage the CRISPR genome editing technologies of Scribe to facilitate in genetic modification of new natural killer (NK) cell therapeutics for cancer. Scribe is also entitled to receive potential payments worth over $1bn on meeting development and commercial milestones.

Engineering 52

Engineering Pharmaceutical Sales 52

pharmaphorum

JULY 21, 2022

It’s worth noting that the agreement has been forged a few months after Merck suffered a setback in its attempt to secure FDA approval for a potentially first-in-class drug for chronic cough – oral P2X3 receptor antagonist gefapixant – on the strength of its effects on 24-hour cough frequency in two placebo-controlled phase 3 trials.

FDA 52

FDA Education Medical Patients 52

PM360

JUNE 29, 2022

Consider the SmartLabel Digital Transparency Initiative, which was created by the Grocery Manufacturers Association and the Food Industry Association under the manufacturing companies’ and retailers’ parity-based entity called the Trading Partner Alliance in 2016. Additionally, Walgreens Boots Alliance (WBA) has made a $5.2

Retail 97

Retail Healthcare Healthcare Marketing 97

pharmaphorum

NOVEMBER 9, 2022

Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 The alliance is backloaded, with $21.5 The post Sanofi signs $1.2bn research alliance with AI specialist Insilico appeared first on.

Pharma 105

Pharma Leads Marketing Medicine 105

World of DTC Marketing

AUGUST 7, 2022

Andrew Witty, its CEO, had a 2021 pay package worth $18.4 Researchers with Aimed Alliance , a non-profit that seeks to protect and enhance the rights of health care consumers and providers, say that doctors are so fed up with the constant headaches caused by insurers that two-thirds would recommend against pursuing a career in medicine.

Insurance 263

Insurance Doctors Government Physicians 263

Pharmaceutical Technology

DECEMBER 22, 2022

Blueprint Medicines wins the Financing award this year after securing significant financing partnerships worth up to $1.25bn. Using genomic tools and genetic knowledge, the alliance will choose programmes with an increased probability of success to reduce research and development expenses.

Medicine 52

Medicine Marketing Pharmaceutical Manufacturing 52

pharmaphorum

NOVEMBER 28, 2022

C4X Discovery Holdings has signed an exclusive global licence worth up to $402 million with AstraZeneca (AZ) for the development and commercialisation of the NRF2 Activator programme. He continued: “The COPD market alone is worth close to $20 billion and rising.”.

Leads 52

Leads Pharma Marketing 52

pharmaphorum

JANUARY 24, 2023

Medicines and medical technology manufacturing delivered annual exports worth over £30 billion ($37 billion) for the UK in 2019, on top of making a £32.1 Notable examples include a pair of 10-year alliances with mRNA specialists Moderna and BioNTech. It’s not all bad news.

Manufacturing 108

Manufacturing Medicine Government Pharmaceutical manufacturing 108

Evolve Your Success

FEBRUARY 21, 2023

It’s mentally and physically draining, but it’s worth it. If it’s worth it to you, then do the word to get what you want out of it. But it’s worth it. Alliance Medical, it’s Ally-Med.com. — That was Chandler and Evan with Alliance Medical and Darkwater Consulting. He nailed it.

Medical sales 52

Medical sales Medical Sales Marketing 52

Cadensee

OCTOBER 31, 2021

32:43 Could you tell us a little bit about GITA, the Global Impact Tech Alliance, which you founded? I founded GITA, Global Impact Tech Alliance, which is a nonprofit that aims to scale the impact tech market. Could you tell us a little bit about GITA, the Global Impact Tech Alliance, which you founded? Nadav Shimoni.

Management 52

Management Marketing Healthcare Healthcare 52

Pharmaceutical Technology

MAY 30, 2023

Launched back in 2021, AION Labs was formed as an alliance between AstraZeneca , Merck , Pfizer and Teva , as well as Amazon and the Israel Biotech Fund. An analysis from GlobalData forecasted $3.3bn worth of spending on AI in drug discovery by 2025, more than triple the $1bn spent in 2019, and a year-on-year growth of 24.4%.

Pharma 84

Pharma Government Prospecting Education 84

Pharmaceutical Technology

JANUARY 10, 2023

billion, which along with maximum potential contingent payments would make the deal worth $1.8 The acquisition news came as the Annual JP Morgan Healthcare Conference was kickstarted in San Francisco on 9 January. AstraZeneca will make an upfront payment of $1.3 billion, as per the release.

Prospecting 98

Prospecting Pharma Pharmaceutical Competition 98

Pharmaceutical Technology

MAY 30, 2023

Launched back in 2021, AION Labs was formed as an alliance between AstraZeneca , Merck , Pfizer and Teva , as well as Amazon and the Israel Biotech Fund. An analysis from GlobalData forecasted $3.3bn worth of spending on AI in drug discovery by 2025, more than triple the $1bn spent in 2019, and a year-on-year growth of 24.4%.

Pharma 52

Pharma Government Prospecting Education 52